144 related articles for article (PubMed ID: 31382203)
21. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
[TBL] [Abstract][Full Text] [Related]
22. Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor.
Li C; Zhang F; Wang X; Chen M
Stem Cell Res; 2024 Jun; 77():103433. PubMed ID: 38718593
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
[TBL] [Abstract][Full Text] [Related]
24. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
[TBL] [Abstract][Full Text] [Related]
25. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
26. Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells of different genders.
Gao Y; Cheng Y; Lin B; Xiao D; Wen J; Xu J; Zheng R; Zhang M; Cai C; Hu J
Stem Cell Res; 2024 Jun; 77():103421. PubMed ID: 38636268
[TBL] [Abstract][Full Text] [Related]
27. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
28. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation in cardiac calsequestrin-2.
Ross S; Holliday M; Lim S; Semsarian C
Stem Cell Res; 2019 May; 37():101450. PubMed ID: 31039485
[TBL] [Abstract][Full Text] [Related]
30. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
31. Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene.
Meraviglia V; Arendzen CH; Freund C; Atsma DE; Mummery CL; Bellin M
Stem Cell Res; 2020 May; 45():101764. PubMed ID: 32315959
[TBL] [Abstract][Full Text] [Related]
32. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
33. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
34. Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line.
Colombani S; Bernardin AA; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Meli AC
Stem Cell Res; 2022 Apr; 60():102727. PubMed ID: 35245853
[TBL] [Abstract][Full Text] [Related]
35. Establishment of an induced pluripotent stem cell line SDQLCHi048-A from a healthy boy donor.
Feng Z; Yang X; Guan J; Song W; Liu Y
Stem Cell Res; 2023 Jun; 69():103115. PubMed ID: 37229976
[TBL] [Abstract][Full Text] [Related]
36. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
37. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
[TBL] [Abstract][Full Text] [Related]
38. Establishment of iPSC line from a Chinese infant (XACHi012-A) with Jervell and Lange-Nielsen syndrome carrying combined KCNQ1 frameshift c.431delC(p.I145Sfs*92) and nonsense c.1175G > A (p.W392X) variants and two iPSC lines from the parents (XACHi013-A, XACHi014-A).
Zhou Y; Wang J; Li H; Li A; Wang G; Tan X; Lei M; Zhang Y
Stem Cell Res; 2021 May; 53():102391. PubMed ID: 34088017
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
40. Generation of an induced pluripotent stem cell line (DHMCi008-A) from an individual with TUBA1A tubulinopathy.
Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
Stem Cell Res; 2022 Jul; 62():102818. PubMed ID: 35636247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
